acetate_only
Salt-form preference and its effect on recovered peptide mass per vial.
Section 1
Contribution
Both submits records and annotates other people's.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.84%
n=10
Suppliers covered
7
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043085 | Tirzepatide | KP | KP-2605-E6030 | Janoshik | 2026-Q2 | 97.71 | 4.30 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043181 | PT-141 (Bremelanotide) | GL Biochem | GLBI-2511-F8417 | PeptideMeter | 2026-Q2 | 97.66 | 2.41 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-041440 | GHRP-6 | QYB | QYB-2602-X5162 | Medutest | 2026-Q1 | 99.71 | 1.93 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043190 | Exenatide | GL Biochem | GLBI-2509-A8203 | Nordanalyt | 2026-Q1 | 98.38 | 3.85 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018709 | GHRP-6 | QSC | QSC-2508-F6725 | Medutest | 2025-Q4 | 99.93 | 4.07 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020462 | Liraglutide | KP | KP-2502-E5076 | Nordanalyt | 2025-Q1 | 99.23 | 7.06 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019792 | GHRP-2 | HJ | HJ-2412-G3929 | Nordanalyt | 2025-Q1 | 98.91 | 5.84 | 96.7 | Buyer-sourced | 1 | FAIL |
| AX-2024-004985 | NAD+ | GGPeps | GGPE-2405-A1540 | Janoshik | 2024-Q4 | 97.58 | 7.92 | 95.6 | Buyer-sourced | 0 | PASS |
| AX-2024-004177 | Semaglutide | WWB | WWB-2410-D2737 | Medutest | 2024-Q4 | 98.76 | 1.19 | — | Laboratory-retained | 0 | PASS |
| AX-2024-004362 | Retatrutide | QSC | QSC-2411-C8332 | Janoshik | 2024-Q4 | 99.05 | 3.40 | — | Supplier-supplied | 0 | PASS |